19-47483973-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_007059.4(KPTN):c.188G>A(p.Arg63Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00121 in 1,613,730 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007059.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KPTN | NM_007059.4 | c.188G>A | p.Arg63Gln | missense_variant | Exon 1 of 12 | ENST00000338134.8 | NP_008990.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 177AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00135 AC: 334AN: 247404Hom.: 1 AF XY: 0.00149 AC XY: 201AN XY: 134546
GnomAD4 exome AF: 0.00122 AC: 1778AN: 1461564Hom.: 2 Cov.: 32 AF XY: 0.00126 AC XY: 916AN XY: 727102
GnomAD4 genome AF: 0.00116 AC: 176AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.00112 AC XY: 83AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
- -
not provided Uncertain:1Benign:1
- -
KPTN: BS2 -
Macrocephaly-developmental delay syndrome Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 63 of the KPTN protein (p.Arg63Gln). This variant is present in population databases (rs142867197, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with KPTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 252672). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KPTN protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
KPTN-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at